Induction of antigen-specific antitumor immunity with adenovirus-transduced dendritic cells

Gene Therapy

Volumn 4, Issue 10, 1997, Pages 1023-1028

  Gong, J ^a   Chen, L ^a   Chen, D ^a   Kashiwaba, M ^a   Manome, Y ^a   Tanaka, T ^a   Kufe, D ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Adenovirus; Antitumor immunity; Dendritic cells; DF3 MUC1; Transduction

Indexed keywords

BETA GALACTOSIDASE; MUCIN LIKE CARCINOMA ASSOCIATED ANTIGEN; TUMOR ANTIGEN;

ADENOVIRUS; ANIMAL CELL; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; GENETIC TRANSDUCTION; IMMUNIZATION; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR IMMUNITY;

ADENOVIRIDAE; ANIMALIA;

EID: 0030862319     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300496     Document Type: Article

References (26)

1. Steinman RM. The dendritic cell system and its role in immunogenicity. Ann Rev Immunol 1991; 9: 271-296.
2. Porgador A, Gilboa E Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes. J Exp Med 1995; 182: 255-260.
3. Mayordomo JI et al. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nature Med 1995; 1: 1297-1302.
4. Celluzzi CM et al. Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity. J Exp Med 1996; 183: 283-287.
5. Zitvogel L et al. Therapy of murine rumors with tumor peptide-pulsed dendritic cells: dependence on T cells. J Exp Med 1996; 183: 87-97.
6. Paglia P, Chiodoni C, Rodolfo M, Colombo MP. Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. J Exp Med 1996; 183: 317-322.
7. Reeves ME et al. Retroviral transduction of human dendritic cells with a tumor-associated antigen gene. Cancer Res 1996; 56: 5672-5677.
8. Henderson RA et al. Human dendritic cells genetically engineered to express high levels of the human epithelial tumor antigen mucin (MUC-1) Cancer Res 1996; 56: 3763-3770.
9. Kufe D et al. Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors. Hybridoma 1984; 3: 223-232.
10. Gendler S et al. A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats. J Biol Chem 1988; 263: 12820-12823.
11. Siddiqui J et al. Isolation and sequencing of a cDNA coding for the human DF3 breast carcinoma-associated antigen. Proc Natl Acad Sci USA 1988; 85: 2320-2323.
12. Ligtenberg MJL, Vos HL, Gennissen AMC, Hilkens J. Episialin, a carcinoma-associated mucin, is generated by a polymorphic gene encoding splice variant with alternative amino termini. J Biol Chem 1990; 265: 5573-5578.
13. Merlo GR et al. Frequent alteration of the DF3 tumor-associated antigen gene in primary human breast carcinomas. Cancer Res 1989; 49: 6966-6971.
14. Ligtenberg MJL, Buijs F, Vos HL, Hilkens J. Suppression of cellular aggregation by high levels of episialin. Cancer Res 1992; 52: 2318-2324.
15. Hayes DF, Silberstein DS, Rodrigue S, Kufe DW. DF3 antigen, a human epithelial cell mucin, inhibits adhesion of eosinophils to antibody-coated targets. J Immunol 1990; 145: 962-970.
16. van de Wiel-van Kemenade E et al. Episialin (MUC1) inhibits cytotoxic lymphocyte-target cell interaction. J Immunol 1993; 151- 767-776.
17. Gimmi CD et al. Breast cancer associated antigen, DF3/MUC1, induces apoptosis of activated human T cells. Nature Med 1996; 2: 1367-1370.
18. Inaba K et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte-macrophage colony-stimulating factor. J Exp Med 1992; 176: 1693-1702.
19. Perey L et al. Tumor selective reactivity of a monoclonal antibody prepared against a recombinant peptide derived from the DF3 human breast carcinoma-associated antigen. Cancer Res 1992; 52: 2563-2568.
20. Steinman RM, Witmer MD. Lymphoid dendritic cells are potent stimulators of the primary mixed leukocyte reaction in mice. Proc Natl Acad Sci USA 1978; 75: 5132-5136.
21. van Voorhis WC et al. Relative efficacy of human monocytes and dendritic cells as accessory cells for T cell replication. J Exp Med 1983; 158: 174-191.
22. Akagi J et al. Therapeutic antitumor response after immunization with an admixture of recombinant vaccinia viruses expressing a modified MUC1 gene and the murine T cell costimulatory molecule B7. J Immunother 1997; 20: 38-47.
23. Chen L et al. Breast cancer selective gene expression and therapy mediated by recombinant adenoviruses containing the DF3/MUC1 promoter. J Clin Invest 1995; 96: 2775-2782.
24. Chen L et al. Selective transgene expression for detection and elimination of contaminating carcinoma cells in hematopoietic stem cell sources. J Clin Invest 1996; 98: 2539-2548.
25. Gong JL et al. Intraepithelial airway dendritic cells: a distinct subset of pulmonary dendritic cells obtained by microdissection. J Exp Med 1992; 172: 797-807.
26. Franke L, Porstman T. A highly sensitive non-radioactive cytotoxicity assay for human target cells. J Immunol Meth 1994; 171. 259-262.